Vrignaud Cédric, Mikdar Mahmoud, Duval Romain, Reininger Luc, Damaraju Vijaya L, Sawyer Michael, Colin Yves, Le Van Kim Caroline, Gelly Jean-Christophe, Etchebest Catherine, Peyrard Thierry, Azouzi Slim
Université de Paris Cité, Inserm, BIGR, Paris, France.
Centre National de Référence pour les Groupes Sanguins, Établissement Français de Sang (EFS), Paris, France.
Transfusion. 2023 Mar;63(3):610-618. doi: 10.1111/trf.17268. Epub 2023 Feb 6.
An antibody directed against a high-prevalence red blood cell (RBC) antigen was detected in a 67-year-old female patient of North African ancestry with a history of a single pregnancy and blood transfusion. So far, the specificity of the proband's alloantibody remained unknown in our immunohematology reference laboratory.
Whole-exome sequencing (WES) was performed on the proband's DNA. The reactivity to the SLC29A1-encoded ENT1 adenosine transporter was investigated by flow cytometry analyses of ENT1-expressing HEK293 cells, and RBCs from Augustine-typed individuals. Erythrocyte protein expression level, nucleoside-binding capacity, and molecular structure of the proband's ENT1 variant were further explored by western blot, flow cytometry, and molecular dynamics calculations, respectively.
A missense variant was identified in the SLC29A1 gene, which encodes the Augustine blood group system. It arises from homozygosity for a rare c.242A > G missense mutation that results in a nonsynonymous p.Asn81Ser substitution within the large extracellular loop of ENT1. Flow cytometry analyses demonstrated that the proband's antibody was reactive against HEK-293 cells transfected with control but not proband's SLC29A1 cDNA. Consistent with this finding, proband's antibody was found to be reactive with At(a-) (AUG:-2), but not AUG:-1 (null phenotype) RBCs. Data from structural analysis further supported that the proband's p.Asn81Ser variation does not alter ENT1 binding of its specific inhibitor NBMPR.
Our study provides evidence for a novel high-prevalence antigen, AUG4 (also called ATAM after the proband's name) in the Augustine blood group system, encoded by the rare SLC29A1 variant allele AUG*04 (c.242A > G, p.Asn81Ser).
在一位有过一次妊娠和输血史的67岁北非裔女性患者中检测到一种针对高频率红细胞(RBC)抗原的抗体。迄今为止,在我们的免疫血液学参考实验室中,先证者同种抗体的特异性仍不清楚。
对先证者的DNA进行全外显子组测序(WES)。通过对表达ENT1的HEK293细胞和奥古斯汀血型个体的红细胞进行流式细胞术分析,研究其对SLC29A1编码的ENT1腺苷转运体的反应性。分别通过蛋白质印迹法、流式细胞术和分子动力学计算进一步探究先证者ENT1变体的红细胞蛋白表达水平、核苷结合能力和分子结构。
在编码奥古斯汀血型系统的SLC29A1基因中鉴定出一个错义变体。它源于一种罕见的c.242A>G错义突变的纯合性,该突变导致ENT1大细胞外环内出现非同义p.Asn81Ser替代。流式细胞术分析表明,先证者的抗体与转染了对照但未转染先证者SLC29A1 cDNA的HEK-293细胞有反应。与这一发现一致,发现先证者的抗体与At(a-)(AUG:-2)红细胞有反应,但与AUG:-1(无效表型)红细胞无反应。结构分析数据进一步支持先证者的p.Asn81Ser变异不会改变其特异性抑制剂NBMPR与ENT1的结合。
我们的研究为奥古斯汀血型系统中一种新的高频率抗原AUG4(也以先证者的名字命名为ATAM)提供了证据,该抗原由罕见的SLC29A1变体等位基因AUG*04(c.242A>G,p.Asn81Ser)编码。